Ticker Details
Seres Therapeutics, Inc. Seres Therapeutics Inc is a microbiome therapeutics platform company which is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics.
IPO Date:	June 26, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$45.8M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 4.12%
Avg Daily Range (30 D):	$0.25 | 4.69%
Avg Daily Range (90 D):	$0.26 | 4.01%

Institutional Daily Volume
Avg Daily Volume:	1.02M
Avg Daily Volume (30 D):	.06M
Avg Daily Volume (90 D):	.06M

Trade Size
Avg Trade Size (Sh.):	175
Avg Trade Size (Sh.) (30 D):	73
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	1,294
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$.75M
Avg Institutional Trade (90 D):	$.75M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.2M
Avg Closing Trade (30 D):	$.66M
Avg Closing Trade (90 D):	$.66M
Avg Closing Volume:	12.55K

News

Apr 20, 2026 @ 11:00 AM Seres Therapeutics Showcases SER-155 Data and Live... Source: Na

Mar 12, 2026 @ 11:00 AM Seres Therapeutics Reports Fourth Quarter and Full... Source: Seres Therapeutics, Inc.

Feb 16, 2026 @ 11:50 AM $3.25+ Bn Human Microbiome Market Trends and Globa... Source: Researchandmarkets.Com

Nov 6, 2025 @ 1:12 AM Seres (MCRB) Q3 2025 Earnings Call Transcript Source: Motley Fool Transcribing

Jun 2, 2025 @ 11:00 AM Denodo University Challenge Now Open: Data and AI ... Source: Denodo

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-2.44	$.47	$-2.08
Diluted EPS	$-2.43	$.47	$-2.08
Revenue	$1.88M	$.74M	$.36M
Gross Profit
Net Income / Loss	$-22.46M	$4.58M	$-19.91M
Operating Income / Loss	$-84.03M	$-21.27M	$-20.91M
Cost of Revenue
Net Cash Flow	$-36.21M	$-36.6M	$M
PE Ratio

Splits
Apr 22, 2025	1:20